In an intradiscal fraction containing PDE6, treatment with Vardenafil at 20 µM increased the mass distribution of PDE6 by 976 Da. In KB-C2 cells, Vardenafil at 10 µM significantly increased intracellular accumulation of [3H]-paclitaxel by 1.6-fold. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Mass spectra of the intradiscal fraction
Cell-based study · intradiscal fraction containing PDE6 [1]
An intradiscal fraction containing PDE6 was treated directly with Vardenafil at 20 µM. Mass spectra showed that the mass distribution of PDE6 increased by 976 Da.
Literature-Reported Treatment Conditions
- Treatment concentration
- 20 µM
- Exposure duration
- at 4 °C for 30 min
- Method
- introduced each drug directly into the intradiscal fraction
- Vehicle
- 200 mM ammonium acetate solution such that the final concentration of DMSO was <1%
Methods and source locations
Compound reported in the paper: Vardenafil
Evidence for Vardenafil as the hydrochloride, trihydrate form reported in the paper, not the free base/neutral form supplied as A10965; no salt equivalence, dose conversion or lot validation.
Results > Off-target drug binding at the single proteoform level (S115, S116); Methods > Drug binding (S208, S209, S211, S212); Fig. 4 legend (S242)
Mass spectra of PDE6: Mass spectra of PDE6; comparator: Controls contained no drug but were diluted with the equivalent DMSO-containing buffer. — Results > Off-target drug binding at the single proteoform level (S116); Fig. 4 legend (S242)
Intracellular paclitaxel accumulation in KB-C2 cells
Cell-based study · KB-C2 [2]
KB-C2 cells were incubated with Vardenafil at 10 µM. Vardenafil significantly increased intracellular accumulation of [3H]-paclitaxel by 1.6-fold.
Literature-Reported Treatment Conditions
- Treatment concentration
- 10 µM
- Exposure duration
- preincubated with or without the reversing agents for 1 h at 37°C
- Method
- incubating cells
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: Vardenafil
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > [3H]-paclitaxel accumulation and efflux (S25, S26); Results > Vardenafil significantly increases the accumulation of intracellular paclitaxel in ABCB1-overexpressing cells by inhibiting drug efflux (S76, S78)
intracellular accumulation of [3H]-paclitaxel: intracellular accumulation of [3H]-paclitaxel; comparator: in the absence and presence of vardenafil — Results > Vardenafil significantly increases the accumulation of intracellular paclitaxel in ABCB1-overexpressing cells by inhibiting drug efflux (S78)